Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity
Jun 25, 2021, 01:26 PM
Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the Wegovy approval for chronic weight management and Novo Nordisk's plans to evaluate an oral version.